Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

PCOS affects many women, causing menstrual issues and infertility, but can be managed with lifestyle changes, medications, and possibly herbal treatments.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

PCOS should be reclassified into two types based on hormone levels and symptoms.

As women age, they experience changes in hair density and volume, face challenges in distinguishing normal hair loss from disease, and have limited access to treatments for hair issues.

Testosterone makes XX skin more like male skin by changing its structure and cell makeup.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Medication can effectively reduce hair growth and improve life quality for women with hirsutism.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Testosterone therapy may help women with low sexual desire after surgical menopause.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

PCOS increases sexual pain distress in infertile women.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

A 12-year-old girl with very high testosterone and insulin resistance improved with birth control pills, suggesting PCOS can cause high testosterone without tumors.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Women with PCOS experience more psychological symptoms and need emotional support.

Hirsutism in young women is often caused by PCOS and managed with lifestyle changes, treatments, and hormonal therapy, which takes 9-12 months to work.

Thai women with PCOS become more aware and change their lifestyle to manage their fertility and symptoms.

Early menarche may indicate higher risk of severe hirsutism in PCOS patients.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

Low estrogen compared to androgen may cause female hair loss.